Abstract
Alongside the scientific barriers to the clinical translation of stem cell research are ethical and regulatory hurdles. Some of these challenges described by the Ethics and Public Policy Committee at the ISSCR Tenth Annual Meeting are presented here.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 765-767 |
| Number of pages | 3 |
| Journal | Cell Stem Cell |
| Volume | 11 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Dec 7 2012 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology
Fingerprint Dive into the research topics of 'Ethical and policy issues in the clinical translation of stem cells: Report of a focus session at the ISSCR tenth annual meeting'. Together they form a unique fingerprint.
Cite this
Kato, K., Kimmelman, J., Robert, J., Sipp, D., & Sugarman, J. (2012). Ethical and policy issues in the clinical translation of stem cells: Report of a focus session at the ISSCR tenth annual meeting. Cell Stem Cell, 11(6), 765-767. https://doi.org/10.1016/j.stem.2012.11.004